Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Abstract

Results support the clinical utility of MPH in the treatment of the PI subtype and provide no evidence of differences in response between the subtypes.